Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Neophytides

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Neurobiology of Aging|January 1, 1981
Central amine metabolism in Alzheimer's disease: in vivo relationship to cognitive deficitJ J Mann, M Stanley, A Neophytides, et al.
Neurology|February 1, 1984
Long-term treatment with pergolide: decreased efficacy with timeA N Lieberman, M Goldstein, M Leibowitz, et al.
New York State Journal of Medicine|November 1, 1981
Use of lisuride in advanced Parkinson's disease. Potent dopamine and serotonin agonistA N Lieberman, M Goldstein, A Neophytides, et al.
Lancet (London, England)|November 24, 1979
Pergolide and lisuride for Parkinson's diseaseA N Lieberman, M Leibowitz, A Neophytides, et al.
New York State Journal of Medicine|October 1, 1979
Bromocriptine mesylate in Parkinson's diseaseA Lieberman, M Kupersmith, A Neophytides, et al.
Neurology|October 1, 1982
Further studies with pergolide in Parkinson diseaseA N Lieberman, M Goldstein, G Gopinathan, et al.
Advances in Neurology|January 1, 1983
Comparative efficacy of pergolide and bromocriptine in patients with advanced Parkinson's diseaseA N Lieberman, A Neophytides, M Leibowitz, et al.
Neurology|May 1, 1980
Long-term efficacy of bromocriptine in Parkinson diseaseA Lieberman, M Kupersmith, A Neophytides, et al.
The American Journal of the Medical Sciences|July 1, 1979
Treatment of Parkinson's disease with dopamine agonists: a reviewA Lieberman, A Neophytides, M Kupersmith, et al.
Advances in Biochemical Psychopharmacology|January 1, 1980
Bromocriptine in Parkinson's disease: report on 106 patients treated for up to 5 yearsA N Lieberman, M Kupersmith, A Neophytides, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Neurobiology of Aging|January 1, 1981
Central amine metabolism in Alzheimer's disease: in vivo relationship to cognitive deficitJ J Mann, M Stanley, A Neophytides, et al.
Neurology|February 1, 1984
Long-term treatment with pergolide: decreased efficacy with timeA N Lieberman, M Goldstein, M Leibowitz, et al.
New York State Journal of Medicine|November 1, 1981
Use of lisuride in advanced Parkinson's disease. Potent dopamine and serotonin agonistA N Lieberman, M Goldstein, A Neophytides, et al.
Lancet (London, England)|November 24, 1979
Pergolide and lisuride for Parkinson's diseaseA N Lieberman, M Leibowitz, A Neophytides, et al.
New York State Journal of Medicine|October 1, 1979
Bromocriptine mesylate in Parkinson's diseaseA Lieberman, M Kupersmith, A Neophytides, et al.
Neurology|October 1, 1982
Further studies with pergolide in Parkinson diseaseA N Lieberman, M Goldstein, G Gopinathan, et al.
Advances in Neurology|January 1, 1983
Comparative efficacy of pergolide and bromocriptine in patients with advanced Parkinson's diseaseA N Lieberman, A Neophytides, M Leibowitz, et al.
Neurology|May 1, 1980
Long-term efficacy of bromocriptine in Parkinson diseaseA Lieberman, M Kupersmith, A Neophytides, et al.
The American Journal of the Medical Sciences|July 1, 1979
Treatment of Parkinson's disease with dopamine agonists: a reviewA Lieberman, A Neophytides, M Kupersmith, et al.
Advances in Biochemical Psychopharmacology|January 1, 1980
Bromocriptine in Parkinson's disease: report on 106 patients treated for up to 5 yearsA N Lieberman, M Kupersmith, A Neophytides, et al.
Pageof 4